• vcard
305.921.1816
  • Education
    • J.D., University of Florida Levin College of Law, 2007
    • Ph.D., University of Florida College of Medicine, 2004, Biomedical Sciences
    • B.A., College of the Holy Cross, 1998, Biology
  • Bar Jurisdictions
    • Florida
    • Georgia
    • Admitted to practice before the United States Patent and Trademark Office
  • Court Admissions
    • U.S. District Court, Southern District of Florida
    • U.S. District Court, Northern District of Georgia

A registered patent attorney with an advanced degree in biomedical sciences, Rebecca McFadyen focuses her practice on all aspects of domestic and international patent prosecution, including inventorship, noninfringement, and invalidity analyses, third-party preissuance submissions, client counseling, and pre-litigation analysis relating to the life sciences and biotechnology technical areas. She works with clients to review, analyze and evaluate intellectual property-related issues to provide a comprehensive overview of the portfolio.

Rebecca has experience in a variety of technologies including DNA and protein therapeutics, biomarkers, stem cell technologies, genetic engineering, transgenic animals, gene therapy, molecular and cellular biological screening assays, vaccines, peptide/protein therapy and diagnostics, algal fermentation, methods of nucleic acid amplification and various biotechnical research tools.

  • Advised a state university and its research foundation in a patent infringement suit against multiple pharmaceutical companies involving various products.
  • Handled complex matters involving cardiovascular and cardiopulmonary medical devices for a multinational medical device corporation.
  • Evaluated scientific and medical information for hernia mesh manufacturer in a high-profile MDL.
text icon Publications & Presentations
Adjustments to Copyright Act Timing Provisions for Applicants Affected by COVID-19
August 14, 2020
text icon Publications & Presentations
Youth Law Day
Speaker, Palm Beach County Bar Association
February 2018
text icon Publications & Presentations
Creating IP Value for Startups Should Focus on Quality Over Quantity
Moderator, AUTM
March 2017
text icon Publications & Presentations
Genomics Era: Patent Strategies to Avoid the Slippery Slope
Speaker, Business of Biotech
February 2017
text icon Publications & Presentations
Will Therasense Finally End the Plague?
Landslide
January 2012
text icon Publications & Presentations
Rule 56 After Therasense – Are We Bound For Change?
Intellectual Property Today
January 2012
text icon Publications & Presentations
Biosimilars - Impact on Biological Discoveries
Speaker, Eastern AUTM
May 2011
text icon Publications & Presentations
Biosimilars, Generics & Patent Management: Statutory Scheme for Patent Disclosure
Speaker, BioFlorida
October 2010
text icon Publications & Presentations
The Plague of Inequitable Conduct
New Jersey Law Journal
April 2010
text icon Publications & Presentations
IDS Ideas - Practice Pointers for Complying with the Duty of Disclosure
September 2009